Larvol Delta - ASLAN-Pharmaceuticals-reports-positive-preliminary-data-from-proofofconcept-study-for-ASLAN004-targeting-atopic-dermatitis

ASLAN004 - ASLAN

http://www.globenewswire.com/news-release/2019/12/02/1954456/0/en/ASLAN-Pharmaceuticals-Reports-Positive-Preliminary-Data-From-Proof-of-Concept-Study-for-ASLAN004-Targeting-Atopic-Dermatitis.html

Dec 2, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next